Clinical Trials · NCT03013387
Dosimetry Guided PRRT With 90Y-DOTATOC
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Sue O'Dorisio
- Enrollment
- 0
- Start date
- Jan 2017
- Locations
- See registry
- Primary endpoint
- Treatment efficacy as assessed by change and defined as complete response, partial response or stable disease (CR+PR+SD)